HPV vaccine implementation in STD clinics--STD Surveillance Network

Sex Transm Dis. 2012 Jan;39(1):32-4. doi: 10.1097/OLQ.0b013e3182315584.

Abstract

We surveyed selected public sexually transmitted disease clinics in the United States regarding human papillomavirus vaccine availability, target populations, funding sources, and barriers. Although nearly all had experience offering other vaccines, only 7 of 42 clinics (17%) offered human papillomavirus vaccine. Vaccine cost, staff time, and follow-up issues were commonly reported barriers.

MeSH terms

  • Adolescent
  • Adult
  • Ambulatory Care Facilities / statistics & numerical data*
  • Child
  • Data Collection
  • Female
  • Follow-Up Studies
  • Health Services Accessibility / statistics & numerical data*
  • Humans
  • Male
  • Papillomavirus Infections / epidemiology
  • Papillomavirus Infections / prevention & control*
  • Papillomavirus Vaccines / administration & dosage*
  • Sentinel Surveillance
  • Sexually Transmitted Diseases / epidemiology
  • Sexually Transmitted Diseases / prevention & control*
  • United States / epidemiology
  • Young Adult

Substances

  • Papillomavirus Vaccines